CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,498,325 | -5.5% | 10,743,324 | +4.6% | 0.01% | 0.0% |
| Q2 2023 | $335,031,180 | -6.5% | 10,270,729 | +0.9% | 0.01% | -11.1% |
| Q1 2023 | $358,351,453 | -22.4% | 10,183,332 | +1.1% | 0.01% | -30.8% |
| Q4 2022 | $461,549,167 | -4.7% | 10,073,094 | +0.8% | 0.01% | -7.1% |
| Q3 2022 | $484,081,000 | +37.5% | 9,991,334 | +11.5% | 0.01% | +40.0% |
| Q2 2022 | $352,047,000 | +9.4% | 8,960,220 | +2.5% | 0.01% | +25.0% |
| Q1 2022 | $321,760,000 | +1.0% | 8,741,124 | +25.1% | 0.01% | +14.3% |
| Q4 2021 | $318,592,000 | +67.7% | 6,989,719 | +31.5% | 0.01% | +40.0% |
| Q3 2021 | $189,942,000 | +103.1% | 5,314,531 | +12.5% | 0.01% | +150.0% |
| Q2 2021 | $93,522,000 | -17.9% | 4,725,689 | -3.5% | 0.00% | -33.3% |
| Q1 2021 | $113,955,000 | +13.7% | 4,899,174 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $100,202,000 | -6.8% | 4,821,989 | -2.9% | 0.00% | -25.0% |
| Q3 2020 | $107,479,000 | -0.2% | 4,964,324 | +8.6% | 0.00% | 0.0% |
| Q2 2020 | $107,743,000 | +93.4% | 4,571,208 | -3.3% | 0.00% | +100.0% |
| Q1 2020 | $55,716,000 | +15.5% | 4,725,736 | +4.0% | 0.00% | 0.0% |
| Q4 2019 | $48,232,000 | -1.7% | 4,545,990 | +5.4% | 0.00% | 0.0% |
| Q3 2019 | $49,063,000 | +10.1% | 4,311,441 | +8.8% | 0.00% | 0.0% |
| Q2 2019 | $44,566,000 | +44.5% | 3,961,497 | +3.9% | 0.00% | +100.0% |
| Q1 2019 | $30,852,000 | +35.5% | 3,813,648 | +5.9% | 0.00% | 0.0% |
| Q4 2018 | $22,764,000 | -32.9% | 3,601,912 | +4.6% | 0.00% | 0.0% |
| Q3 2018 | $33,917,000 | +19.6% | 3,443,358 | +0.8% | 0.00% | 0.0% |
| Q2 2018 | $28,349,000 | +16.0% | 3,415,490 | +0.6% | 0.00% | 0.0% |
| Q1 2018 | $24,434,000 | -13.1% | 3,393,643 | -1.6% | 0.00% | 0.0% |
| Q4 2017 | $28,123,000 | -42.8% | 3,450,568 | +1.9% | 0.00% | -50.0% |
| Q3 2017 | $49,124,000 | +30.2% | 3,387,871 | +8.7% | 0.00% | 0.0% |
| Q2 2017 | $37,721,000 | +50.6% | 3,117,496 | +59.9% | 0.00% | +100.0% |
| Q1 2017 | $25,049,000 | +22.6% | 1,949,345 | +15.9% | 0.00% | 0.0% |
| Q4 2016 | $20,435,000 | +23.9% | 1,681,908 | -6.4% | 0.00% | 0.0% |
| Q3 2016 | $16,499,000 | -3.7% | 1,797,337 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $17,125,000 | +65.3% | 1,804,613 | +22.8% | 0.00% | 0.0% |
| Q1 2016 | $10,363,000 | -22.9% | 1,469,958 | +14.4% | 0.00% | 0.0% |
| Q4 2015 | $13,437,000 | -92.2% | 1,284,618 | -81.4% | 0.00% | -83.3% |
| Q3 2015 | $172,413,000 | +2159.7% | 6,898,246 | +507.5% | 0.01% | +500.0% |
| Q2 2015 | $7,630,000 | +0.9% | 1,135,452 | +1.8% | 0.00% | 0.0% |
| Q1 2015 | $7,562,000 | -24.1% | 1,115,341 | -10.4% | 0.00% | 0.0% |
| Q4 2014 | $9,967,000 | +124.8% | 1,244,385 | -1.2% | 0.00% | – |
| Q3 2014 | $4,433,000 | -23.4% | 1,259,276 | +4.0% | 0.00% | – |
| Q2 2014 | $5,790,000 | -45.4% | 1,211,321 | +8.6% | 0.00% | -100.0% |
| Q1 2014 | $10,597,000 | +104.0% | 1,115,401 | +39.6% | 0.00% | – |
| Q4 2013 | $5,194,000 | -3.3% | 799,064 | +12.9% | 0.00% | -100.0% |
| Q3 2013 | $5,372,000 | – | 707,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |